Chemical Compound Review:
AC1L9HAR 1-[(2R,4S)-4-[(2S,4S,5S,6S)- 4-amino-5...
Synonyms:
1i1e
- 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent. Tsuruo, T., Iida, H., Tsukagoshi, S., Sakurai, Y. Cancer Res. (1982)
- Prevention of anthracycline-induced cytotoxicity in hemopoietic cells by hemin. Tsiftsoglou, A.S., Wong, W., Wheeler, C., Steinberg, H.N., Robinson, S.H. Cancer Res. (1986)
- Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. Fogo, A., Yoshida, Y., Glick, A.D., Homma, T., Ichikawa, I. J. Clin. Invest. (1988)
- Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary. Wilson, A.P. J. Natl. Cancer Inst. (1984)
- Cycle-dependent anticancer drug cytotoxicity in mammalian cells synchronized by centrifugal elutriation. Meyn, R.E., Meistrich, M.L., White, R.A. J. Natl. Cancer Inst. (1980)
- Chemotherapy of pancreatic adenocarcinoma: initial report on two transplantable models in the Syrian hamster. Chang, B.K., Gutman, R. Cancer Res. (1982)
- ATP/Mg2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells. Naito, M., Hamada, H., Tsuruo, T. J. Biol. Chem. (1988)
- Cytotoxic effect in vivo of selected chemotherapeutic agents on synchronized murine fibrosarcoma cells. Grdina, D.J., Sigdestad, C.P., Peters, L.J. Br. J. Cancer (1980)
- Immunomorphometric studies of proteinuria in individual deep and superficial nephrons of rats. Hoyer, J.R., Fogo, A.B., Terrell, C.H., Delaney, M.M. Lab. Invest. (2000)
- In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative. Pierré, A., Dunn, T.A., Kraus-Berthier, L., Léonce, S., Saint-Dizier, D., Régnier, G., Dhainaut, A., Berlion, M., Bizzari, J.P., Atassi, G. Investigational new drugs. (1992)
- Supramolecular complex formation between Rad6 and proteins of the p53 pathway during DNA damage-induced response. Lyakhovich, A., Shekhar, M.P. Mol. Cell. Biol. (2003)
- Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells. Watanabe, M., Komeshima, N., Naito, M., Isoe, T., Otake, N., Tsuruo, T. Cancer Res. (1991)
- Flow cytometric localization within the cell cycle and isolation of viable cells following exposure to cytotoxic agents. Crissman, H.A., Wilder, M.E., Tobey, R.A. Cancer Res. (1988)
- ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. Tang, D., Wu, D., Hirao, A., Lahti, J.M., Liu, L., Mazza, B., Kidd, V.J., Mak, T.W., Ingram, A.J. J. Biol. Chem. (2002)
- Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line. Ivy, S.P., Tulpule, A., Fairchild, C.R., Averbuch, S.D., Myers, C.E., Nebert, D.W., Baird, W.M., Cowan, K.H. J. Biol. Chem. (1988)
- Effects of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and structural analogues on DNA in HT-29 human colon carcinoma cells. Jesson, M.I., Johnston, J.B., Anhalt, C.D., Begleiter, A. Cancer Res. (1987)
- Possible link between the intrinsic drug resistance of colon tumors and a detoxification mechanism of intestinal cells. Klohs, W.D., Steinkampf, R.W. Cancer Res. (1988)
- Laser flow cytometric studies on the intracellular fluorescence of anthracyclines. Krishan, A., Ganapathi, R. Cancer Res. (1980)
- Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit. Jaenke, R.S., Deprez-DeCampeneere, D., Trouet, A. Cancer Res. (1980)
- Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Fan, S., Wang, J.A., Yuan, R.Q., Rockwell, S., Andres, J., Zlatapolskiy, A., Goldberg, I.D., Rosen, E.M. Oncogene (1998)
- Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. Koshikawa, M., Mukoyama, M., Mori, K., Suganami, T., Sawai, K., Yoshioka, T., Nagae, T., Yokoi, H., Kawachi, H., Shimizu, F., Sugawara, A., Nakao, K. J. Am. Soc. Nephrol. (2005)
- Emergence of different mechanisms of resistance in the evolution of multidrug resistance in murine erythroleukemia cell lines. Modrak, D.E., Draper, M.P., Levy, S.B. Biochem. Pharmacol. (1997)
- In vitro cytotoxicity of S16020-2, a new olivacine derivative. Léonce, S., Perez, V., Casabianca-Pignede, M.R., Anstett, M., Bisagni, E., Pierré, A., Atassi, G. Investigational new drugs. (1996)
- Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells. Yuan, R., Fan, S., Wang, J.A., Meng, Q., Ma, Y., Schreiber, D., Goldberg, I.D., Rosen, E.M. Prostate (1999)
- Kinetics of p53 binding to promoter sites in vivo. Szak, S.T., Mays, D., Pietenpol, J.A. Mol. Cell. Biol. (2001)
- Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Bland, K.I., Palin, W.E., von Fraunhofer, J.A., Morris, R.R., Adcock, R.A., Tobin, G.R. Ann. Surg. (1984)
- Overcoming multi-drug resistance using an intracellular anti-MDR1 sFv. Heike, Y., Kasono, K., Kunisaki, C., Hama, S., Saijo, N., Tsuruo, T., Kuntz, D.A., Rose, D.R., Curiel, D.T. Int. J. Cancer (2001)
- Injectable microspheres with controlled drug release for glaucoma filtering surgery. Kimura, H., Ogura, Y., Moritera, T., Honda, Y., Wada, R., Hyon, S.H., Ikada, Y. Invest. Ophthalmol. Vis. Sci. (1992)